Inflammatory bowel disease: past, present, and future
Open Access
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in The Esophagus
- Vol. 42 (1), 16-25
- https://doi.org/10.1007/s00535-006-1995-7
Abstract
Crohn’s disease and ulcerative colitis, collectively known as the inflammatory bowel diseases (IBD), are largely diseases of the twentieth century, and are associated with the rise of modern, Westernized industrial society. Although the causes of these diseases remain incompletely understood, the prevailing model is that the intestinal flora drives an unmitigated intestinal immune response and inflammation in the genetically susceptible host. A review of the past and present of these diseases shows that detailed description preceded more fundamental elucidation of the disease processes. Working out the details of disease pathogenesis, in turn, has yielded dividends in more focused and effective therapy for IBD. This article highlights the key descriptions of the past, and the pivotal findings of current studies in disease pathogenesis and its connection to medical therapy. Future directions in the IBD will likely explicate the inhomogeneous causes of these diseases, with implications for individualized therapy.Keywords
This publication has 100 references indexed in Scilit:
- Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trialGut, 2006
- Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1–dependent pathwayThe Journal of Experimental Medicine, 2005
- Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's DiseaseNew England Journal of Medicine, 2005
- Infliximab Maintenance Therapy for Fistulizing Crohn's DiseaseNew England Journal of Medicine, 2004
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- The expanding universe of T-cell subsets: Th1, Th2 and moreImmunology Today, 1996
- Lymphocyte responses and cytokinesCell, 1994
- Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileumThe Lancet, 1991
- Favorable effect of 6-Mercaptopurine on fistulae of Crohn's diseaseDigestive Diseases and Sciences, 1985
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980